This excerpt taken from the CBRX 8-K filed Jul 7, 2008.
Columbia Laboratories, Inc. in Item 4.01(a) of the accompanying Form 8-K, which is being filed with the Securities and Exchange Commission. We agree with the statements in Item 4.01(a) concerning our firm. We have no basis to agree or disagree with the Registrant’s belief that the material weakness has been remediated as we have not audited that assertion.
Very truly yours,
/s/ McGladrey & Pullen, LLP
McGLADREY & PULLEN, LLP